Delivery Order SPE2DB22D3016-SPE2DB25FBAP9
- Not listed
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lenvima 14 mg daily dose (60-count package), with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lenvima 8 mg daily dose tablets (60-count supply) with a completion deadline of August 20, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) awarded a $10,773.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lenvima 8 mg daily dose tablets (60-unit supply) on October 27, 2025, with completion targeted for November 18, 2025. This award represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp for Lenvima 18 mg daily dose, a 90-day supply. The contract is a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs...
- The Defense Logistics Agency awarded a $9,910.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 MG daily dose (60-count supply) on June 18, 2025, with completion targeted for July 11, 2025. This non-set-aside contract represents a direct pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count quantity, with a ceiling value of $10,223.24 and a firm fixed price structure. The contract carries an ultimate completion date of November 18, 2025, and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose tablets (30-count supply) on November 3, 2025, with completion targeted for November 25, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for the supply of Lenvima 18 mg daily dose tablets (90-count package). This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 26, 2025, and represents fulfillment under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count) with a ceiling value of $10,223.24. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by November 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order valued at $19,821.90 to AmerisourceBergen Drug Corp for LENVIMA 20 mg daily dose tablets (60-count supply). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 16, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBAP9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for Lenvima 10 mg daily dose tablets (30-count package) on June 30, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems. The delivery order is issued under a child contract mechanism, leveraging the company's broader pharmaceutical supply capabilities. This delivery order is supported by AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of brand-name and generic medications, vaccines, and specialized medical commodities to support military healthcare programs worldwide. The current delivery order for Lenvima—a specialty oncology medication—exemplifies the company's role in fulfilling critical pharmaceutical needs for the Defense Health Agency and other federal healthcare systems through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 6/30/25 |